Tiny Drug-Laden ‘Popping Bubbles’ Lead Triple Attack Treatment for Liver Cancer

December 8, 2015

(Physorg) – In an interdisciplinary collaboration between prominent academic and industry investigators, researchers have discovered a novel method for repositioning an FDA-approved anti-cancer compound so it can specifically target liver cancer tumors. A ‘triple attack’ technique combining chemotherapy, thermal ablation, and hyperthermia provided a highly targeted, yet minimally invasive approach.